Article Details

Mitigating Patent Cliff Fallout - BioSpectrum Asia

Retrieved on: 2025-03-01 17:35:10

Tags for this article:

Click the tags to see associated articles and topics

Mitigating Patent Cliff Fallout - BioSpectrum Asia. View article details on hiswai:

Excerpt

Monoclonal antibodies (mAbs) represent a $279.8 billion market ... monoclonal antibody injection) in China. Prolia (denosumab). Company: Amgen.

Article found on: www.biospectrumasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo